KALY Announces Hemp4mula CBD Gum NOW Available On USMJ.com

Dallas, TX -- April 22, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) announced today that its Hemp4mula CBD gum is now available for sale on line at USMJ.com. KALY acquired a patented cannabis extraction process in the fourth quarter of 2019 and has rapidly implemented a multitiered strategy to monetize the value of the patented process. The company has recently announced a $300,000 order of its proprietary extract and revealed four years of research and development targeting $170 billions worth of pharmaceutical treatments. The announcement today is a further indication of KALY’s progress toward a $1 million revenue target for 2018 in addition to potentially building billions in asset value from its ongoing cannabis extract pharmaceutical research and development.

https://usmj.com/product/hemp4mula-gum-tablets-8pk/

USMJ.com is a cannabis Ecommerce site delivered by North American Cannabis Holdings, Inc. (USOTC: USMJ).

To learn more about the company visit https://www.kali-extracts.com/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459